definiens: shall mean only the following costs incurred, on a cash basis, by Alimera for Commercializing a Product in accordance with this Agreement and pursuant to the Commercialization Budget : ( a ) Direct Costs of marketing activities for the Product, including pre‐launch, launch, advertising, packaging, activities necessary for seeking and maintaining pricing and reimbursement approvals from Third Party payors, literature, lectures, training ( including wet labs for training healthcare professionals ) and sales promotion ; 7/15/2016 https://www.sec.gov/Archives/edgar/data/1314102/000095012306000446/y16393exv4w13.txthttps://www.sec.gov/Archives/edgar/data/1314102/000095012306000446/y16393exv4w13.txt 9/66 ( b ) [ * ] ( c ) Direct Costs associated with maintaining Approvals for the Product ; ( d ) Direct Costs of package development and package maintenance for the Product ; ( e ) Selling Expenses for the Product ; ( f ) Manufacturing Costs to satisfy Commercial Supply Requirements for the Product ; ( g ) Direct Costs of distribution of the Product other than the costs specified in Section 1.60(d ) ; [ * ] ‐ INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED . ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE COMMISSION PURSUANT TO RULE 24b‐2 PROMULGATED UNDER THE SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED